Lipoid pneumonia historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
In 1925,G. F. LAUGHLEN, M.D. was  the first [[physician]] to describe [[lipoid pneumonia]]. he first interacted to the disease by routine [[autopsy]] at the Toronto, Ontorio hospital for sick children. he described grayish red nodules at the autopsy with three types of [[Exudate|exudates]], found out [[Monocyte|mononuclear]] cells which were unexpected in the [[Exudate|exudates]]. in 1949 McDonald et al described endogenous [[lipoid pneumonia]] for the first time. he observed so called "obstructive [[pneumonia]]" in patients with [[Lung cancer|lung neoplasms]].
In 1925,G. F. LAUGHLEN, M.D. was  the first [[physician]] to describe [[lipoid pneumonia]]. He first interacted to the disease by routine [[autopsy]] at the Toronto, Ontorio hospital for sick children. He described grayish red nodules at the autopsy with three types of [[Exudate|exudates]], found out [[Monocyte|mononuclear]] cells which were unexpected in the [[Exudate|exudates]]. In 1949 McDonald et al described endogenous [[lipoid pneumonia]] for the first time. He observed so called "obstructive [[pneumonia]]" in patients with [[Lung cancer|lung neoplasms]].


==Historical Perspective==
==Historical Perspective==
Line 17: Line 17:
*In 1949 McDonald et al described endogenous [[lipoid pneumonia]] for the first time.<ref name="pmid18110247">{{cite journal| author=McDONALD JR, HARRINGTON SW, CLAGETT OT| title=Obstructive pneumonitis of neoplastic origin; an interpretation of one form of so-called atelectasis and its correlation according to presence of absence of sputum. | journal=J Thorac Surg | year= 1949 | volume= 18 | issue= 1 | pages= 97-112; disc., 122 | pmid=18110247 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18110247  }}</ref>
*In 1949 McDonald et al described endogenous [[lipoid pneumonia]] for the first time.<ref name="pmid18110247">{{cite journal| author=McDONALD JR, HARRINGTON SW, CLAGETT OT| title=Obstructive pneumonitis of neoplastic origin; an interpretation of one form of so-called atelectasis and its correlation according to presence of absence of sputum. | journal=J Thorac Surg | year= 1949 | volume= 18 | issue= 1 | pages= 97-112; disc., 122 | pmid=18110247 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18110247  }}</ref>
*He observed so called "obstructive [[pneumonia]]" in patients with [[Lung cancer|lung neoplasms]].
*He observed so called "obstructive [[pneumonia]]" in patients with [[Lung cancer|lung neoplasms]].
*


<br />


==References==
==References==

Revision as of 03:54, 9 October 2019

Lipoid pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lipoid pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lipoid pneumonia historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lipoid pneumonia historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lipoid pneumonia historical perspective

CDC on Lipoid pneumonia historical perspective

Lipoid pneumonia historical perspective in the news

Blogs on Lipoid pneumonia historical perspective

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Lipoid pneumonia historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]

Overview

In 1925,G. F. LAUGHLEN, M.D. was the first physician to describe lipoid pneumonia. He first interacted to the disease by routine autopsy at the Toronto, Ontorio hospital for sick children. He described grayish red nodules at the autopsy with three types of exudates, found out mononuclear cells which were unexpected in the exudates. In 1949 McDonald et al described endogenous lipoid pneumonia for the first time. He observed so called "obstructive pneumonia" in patients with lung neoplasms.

Historical Perspective

Discovery

  • In 1925,G. F. LAUGHLEN, M.D. was the first physician to describe exogenus lipoid pneumonia.[1]
  • He first interacted to the disease by routine autopsy at the Toronto, Ontorio hospital for sick children.
  • He described grayish red nodules at the autopsy with three types of exudates, found out mononuclear cells which were unexpected in the exudates.
  • All of his 4 observed cases underwent laxative and nasal drop therapy regimen.
  • In 1949 McDonald et al described endogenous lipoid pneumonia for the first time.[2]
  • He observed so called "obstructive pneumonia" in patients with lung neoplasms.


References

  1. Laughlen GF (July 1925). "Studies on Pneumonia Following Naso-Pharyngeal Injections of Oil". The American Journal of Pathology. 1 (4): 407–414.1. PMC 1931653. PMID 19969662.
  2. McDONALD JR, HARRINGTON SW, CLAGETT OT (1949). "Obstructive pneumonitis of neoplastic origin; an interpretation of one form of so-called atelectasis and its correlation according to presence of absence of sputum". J Thorac Surg. 18 (1): 97–112, disc., 122. PMID 18110247.

Template:WH Template:WS